Skip to main content
Clinical Trials/JPRN-jRCTs032180164
JPRN-jRCTs032180164CompletedPhase 2

Rehabilitation trial using robotic wear curara(R) for patients with cerebrovascular and neurodegenerative diseases. part 2 spinocerebellar degeneration

Yoshida Kunihiro0 sites20 target enrollmentStarted: February 27, 2019Last updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
20

Study Overview

Brief Summary

We conducted a single-arm study using curara for cerebellar ataxia patients. Of 20 patients enrolled, 19 completed the program without any adverse effects and one withdrew on day 3. The mean improvement rate of 10 m walking time in this study was almost equivalent to that in the previous study, which was a multidisciplinary, intensive, inpatient rehabilitation program of 28 days. We think gait training with curara is potentially useful for cerebellar ataxia patients.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to ot applicable (—)
Sex
All

Inclusion Criteria

  • 1) Patients with spinocerebellar degeneration (SCD)
  • 2) Age: 20 years <= at entry
  • 3) Able to walk 10 m (even with walking aids such as cane or walker)
  • 4) Able to keep admission in Kakeyu-Misayama Rehabilitation Center, Kakeyu Hospital during the study
  • 5) Berg Balance Scale: 20 <=
  • 6) Written informed consent for the study

Exclusion Criteria

  • 1) Possible causes for gait disturbance other than SCD
  • 2) Not fulfil the body-size criteria for curara(R) model 4
  • 3) Researchers judge the participants inappropriate for the study (for example, severe dementia or psychiatric symptoms, severe spasticity or joint contractures of the legs)

Investigators

Sponsor
Yoshida Kunihiro

Similar Trials